Health Products

VITEK 2 System Susceptibility and VITEK 2 Compact 30 and 60 System - Susceptibility Test Cards (2018-10-15)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
All
Manufacturer
bioMerieux Inc.
100 Rudolphe Street
Durham NC
USA 27712
B. VITEK 2 Compact 60 System - Susceptibility Test Cards410 028
All
Manufacturer
bioMerieux Inc.
100 Rudolphe Street
Durham NC
USA 27712
C. VITEK 2 System - Susceptibility Test Cards410 028
All
Manufacturer
bioMerieux Inc.
100 Rudolphe Street
Durham NC
USA 27712
VITEK 2 Compact 30 System - Susceptibility Test Cards410 028

Introduction

Affected products
  1. VITEK 2 Compact 30 System - Susceptibility Test Cards
  2. VITEK 2 Compact 60 System - Susceptibility Test Cards
  3. VITEK 2 System - Susceptibility Test Cards

Reason

Customers in Europe reported false resistant Ceftriaxone results for Streptococcus anginosus and Streptococcus constellatus strains when using VITEK 2 AST-ST01 and AST-ST03 cards and VITEK 2 Systems Software 8.01 with EUCAST breakpoints. These false resistant results were reproduced internally by testing customer strains. A Ceftriaxone MIC overestimation was observed compared to the reference result. An internal study confirmed the performance of Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius had shifted for Ceftriaxone. With EUCAST Global European-based breakpoints, having no Intermediate MIC, this may constitute a category difference. Many strains demonstrated a result of MIC=1 (R) with EUCAST breakpoints, when an MIC=1 remains susceptible (S) for CLSI, Global CLSI-based and FDA breakpoints. The VITEK 2 Ceftriaxone test is included on all AST-ST cards intended for testing streptococci. All lots of AST-ST01, AST-ST02, and AST-ST03 are impacted and are distributed globally.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime